SPONSOR
Hunan Cancer Hospital
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 1, Phase 2
Conditions studied: Hepatocellular CarcinomaTriple Negative Breast NeoplasmsNasopharyngeal CarcinomaHerpesvirus 4, HumanNasopharyngeal Cancinoma (NPC)Metastatic HER2 Negative Breast CarcinomaBrain MetastasesCapecitabineUDT1
NCT06406634 Phase 2
Recruiting
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT06385990 Phase 2
Recruiting
Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
Triple Negative Breast Neoplasms
NCT06321939
Recruiting
Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
NCT06788002 Phase 2
Recruiting
LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
Nasopharyngeal Cancinoma (NPC)
NCT05535413 Phase 1, Phase 2
Recruiting
UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Metastatic HER2 Negative Breast Carcinoma